$4,997. Thirteen months. Weight loss is the side effect — not the goal.

Stay with me.

For the woman whose TSH came back “normal” while her Free T3, Reverse T3, SHBG, and hs-CRP told a different story — if anyone had bothered to run them.

Where “normal labs” stop making sense.

Begin the application →

You already know how this goes.

You brought her the fatigue. She ran a TSH. It came back 2.4. She told you that was normal.

She did not run Free T3. She did not run Reverse T3. She did not run SHBG, or hs-CRP, or a morning cortisol, or a ferritin with a full iron panel. She ran the one marker her training told her to run, and when it landed inside a reference range designed for the general population — not for you — she closed the chart.

The weight gain was eating too much.

The brain fog was stress.

The hair thinning was age.

The cold hands were circulation.

The anxiety was hormonal — vaguely, gesturally, without specificity, and certainly without a workup.

You left with a prescription you did not need, a dismissal you did not deserve, and the growing suspicion that the woman in the mirror knows more about her own body than the woman holding the chart.

You were right.

Your labs were not normal. They were incomplete.

There is a difference between a thyroid that is functioning and a thyroid axis that is optimized. There is a difference between a TSH inside reference range and a Free T3 to Reverse T3 ratio above 2.0. There is a difference between a clinician who orders the minimum and a clinician who orders what the symptom picture actually demands.

For thirteen months, you will work with one who does the latter.

Bernadette Spencer RN, MSN, FNP-C, FMACP Board-Certified Family Nurse Practitioner Telehealth · New York State

"The clinician who was told she was one of those patients."

Before I was the provider who runs the full panel, I was the patient whose cardiologist told her she was one of those patients who thinks she's smarter than the endocrinologist.

I was forty-nine. I had just had a heart attack. My TPO antibodies were over nine hundred.

I am a board-certified Family Nurse Practitioner. I am a veteran. I spent years practicing inside corrections, nursing homes, and hospitalist medicine before I ever opened a functional medicine chart. I know what the standard of care is. I know what it misses. I know it because I watched it miss me — while I was wearing the same credential as the woman dismissing me.

That is the part nobody in functional medicine wellness writes about. It is not that I did not know the system. It is that the system did not care that I knew it. A nurse practitioner with a thyroid antibody count high enough to constitute a medical emergency and a cardiac event already on her chart was still, to that cardiologist, one of those patients.

If that was her posture toward me, imagine her posture toward the thirty-one-year-old teacher who brings her the same symptoms without the credentials to push back.

That woman is who I built this practice for.

What this practice is not

It is not a supplement protocol. It is not a detox program. It is not a twelve-week challenge. It is not a coaching container where we talk about mindset while your Free T3 languishes.

It is a thirteen-month clinical relationship with a licensed nurse practitioner who will order the labs your primary care physician should have ordered, interpret them against functional ranges rather than reference ranges, work in coordination with your existing PCP rather than in opposition to her, and stay with you through four seasons in Western New York because hormonal recalibration does not happen in eight weeks.

Weight loss is the side effect. Restoration is the goal.

Stay with me.

"What the standard of care is designed to do. And what it is not."

The standard of care is not broken. It is functioning exactly as it was designed to function.

It was designed to identify frank pathology in populations — not to restore function in individuals. It was designed to rule out disease — not to explain symptoms. It was designed around reference ranges that capture ninety-five percent of the tested population, which means by definition five percent of women with legitimate dysfunction will test inside the range. It was designed for a fifteen-minute visit, a single marker, and a decision tree that ends in prescribe or reassure.

You are the woman it was not designed for.

Here is what that looks like in practice. The thyroid is treated. The axis is not.

A TSH above range gets levothyroxine. A TSH inside range gets nothing. Neither answer addresses what the pituitary is actually responding to, what the thyroid is actually producing, whether T4 is converting to Free T3 or shunting to Reverse T3, or whether the Free T3 that is produced is reaching the cell. The axis has four checkpoints. Standard care measures one.

The adrenal contribution is invisible.

Chronic HPA activation drives the Reverse T3 shunt, suppresses LDL receptor expression, and sustains the inflammatory state that elevates hs-CRP. It is the engine underneath half of what the reader is experiencing. Standard care does not order a morning cortisol, does not interpret DHEA-S against age-adjusted optimal, and does not recognize the patient in front of it as HPA-driven until she is already in frank adrenal insufficiency.

The gonadal signal is missed entirely. Low SHBG is among the earliest markers of insulin resistance, HPG dysfunction, and hepatic stress. It precedes a movement in A1c by years. It precedes a clinical PCOS diagnosis by longer. It is almost never on a standard panel, and when it is ordered, it is rarely interpreted against the functional range that would make it clinically useful.

The inflammatory picture is absent.

hs-CRP above 3 mg/L in a woman with elevated LDL is not a lipid problem. It is a signal that the HPA axis is contributing to — and potentially driving — the cardiovascular picture. Standard lipid panels do not include it. Standard cardiology workups rarely add it. The woman with a ten-year pre-event inflammatory signal leaves the office told her cholesterol is a little high, watch your diet.

The result: A woman who is tested inadequately, interpreted against the wrong ranges, and dismissed on the basis of findings that were never designed to answer the question she came in asking.

And then told she is anxious.

"What thirteen months with me looks like instead."

Full panel at baseline. HPT, HPA, and HPG axes interpreted against functional ranges, not reference ranges. The Free T3 to Reverse T3 ratio calculated. SHBG interpreted against hepatic and metabolic context. hs-CRP interpreted against HPA load. Cortisol and DHEA-S interpreted against the patient's life — not against the lab's demographic average.

Then the protocol. Diet, exercise, stress architecture, sleep architecture, nutrient repletion, lab-guided supplementation where indicated, and coordination with your PCP so that the work we do functionally and the work she does medically are not in conflict.

Then repeat panels at ninety days, one hundred eighty days, and at the thirteen-month mark.

That is what the standard of care is not designed to provide.

That is what you will receive.

"What happens when the axis is actually treated."

The body is not the enemy. It never was.

Every symptom the reader has been dismissed for — the fatigue that sleep does not repair, the weight that diet does not move, the cycle that has become unpredictable, the hair in the shower drain, the cold hands in a warm room, the anxiety that arrives without a cause — is the body reporting accurately on conditions inside the axis. The symptoms are not the problem. The symptoms are the diagnostic signal.

A clinician who knows how to read them finds the dysfunction. A clinician who does not, prescribes around them.

Here is what changes when the axis is treated — not the thyroid, not the symptom, the axis.

Within ninety days

Morning energy returns before the afternoon crash does. This is the first marker most women notice, and it is the first marker the panel confirms — Free T3 rising into optimal, Reverse T3 falling, cortisol curve beginning to flatten into the physiologic shape it is supposed to hold.

Sleep begins to consolidate. Not immediately. But the three AM cortisol spike that has been waking her for years begins to soften as the HPA axis learns that it is no longer required to run the system alone.

The cycle begins to report accurately. For the premenopausal woman, that means luteal phase lengthens, PMS intensity drops, cycle predictability returns. For the perimenopausal woman, it means vasomotor symptoms begin to space out and the cognitive fog begins to lift between them.

Between ninety and one hundred eighty days

The inflammatory picture changes. hs-CRP drops. LDL receptor expression improves as Free T3 comes online. Blood sugar stabilizes as the HPA axis stops driving compensatory cortisol-mediated gluconeogenesis every time she skips a meal.

Weight begins to move. Not dramatically. Not in the way the GLP-1 advertisements promise. But in the way that the body releases weight when it is no longer holding it for metabolic protection — slowly, steadily, and without the rebound that restrictive dieting produces.

Antibodies begin to move for the Hashimoto's patient. Not to zero. But measurably, and in the direction that tells the clinician the immune provocation is losing its upstream driver.

By month thirteen

The reader is in a different relationship with her body than she was when she entered. She knows her numbers. She knows what each marker is doing and why. She knows what hers look like when she is in a good metabolic window and what they look like when she is slipping. She knows what to ask her PCP for and how to interpret the answer when she gets it.

She has become the patient her old clinician accused her of being — the one who knows more about her body than the chart. Except now she has the labs to prove it.

Not cure. Not remission. Restoration. Of function. Of signal. Of the quiet confidence that comes from understanding the machine you have been living inside.

"You have not been failing the advice. You have been receiving the wrong advice."

Eat less. Exercise more. Watch your diet. Manage your stress.

These are not recommendations. They are what a clinician says when she does not know which axis is driving the dysfunction, does not have the labs that would tell her, and does not have the time in a fifteen-minute visit to find out.

The advice is generic because the workup was generic. Generic advice applied to a specific dysfunction does not produce modest results. It produces the reader — exhausted, compliant, following the guidance she was given, and watching her body respond as if the guidance were addressed to someone else.

It was.

Consider three women who walk into the same primary care office on the same afternoon.

The first — thirty-eight · HPT-primary

She has gained twenty-two pounds in the last two years without a meaningful change in her diet. Her cycle has become unpredictable. She is cold all the time. Her hair is thinning at the temples. Her TSH is 3.1. Her Free T3 is at the floor of the range. Her Reverse T3 is elevated. Her ratio is below 2.0. She is HPT-primary. Her protocol requires adequate dietary iodine and selenium, meaningful protein at each meal to support conversion, strength training that builds mitochondrial density without spiking cortisol, and a specific meal-timing structure that supports thyroid hormone production across the day. Restrictive dieting and high-intensity cardio will deepen the Reverse T3 shunt and make her worse.

The second — forty-four · HPG-primary with early metabolic involvement

Her weight has shifted toward the midsection. Her cycle is still regular but her luteal phase has shortened. Her SHBG is low. Her fasting insulin is elevated. Her LDL has climbed. Her thyroid panel looks unremarkable at standard ranges. She is HPG-primary with early metabolic involvement. Her protocol requires a meaningfully different macronutrient architecture — lower glycemic load, higher fiber, strategic carbohydrate placement around resistance training — and a training structure that prioritizes insulin sensitivity and muscle protein synthesis. The advice that would help the first woman would do almost nothing for her.

The third — fifty-one · HPA-primary with HPT consequences

She is thin. She does not sleep. She wakes at three AM reliably. Her hs-CRP is elevated. Her morning cortisol is high. Her DHEA-S has collapsed. Her Free T3 is low but her TSH is inside range. She is HPA-primary with HPT consequences. Her protocol requires the opposite of the first two — more caloric adequacy, not less; less training intensity, not more; strict circadian anchoring of meals, light exposure, and sleep architecture; and a staged approach to nutrient repletion that respects the adrenal exhaustion underneath the picture. Telling her to eat less and exercise more would actively harm her.

Three women. Three axes. Three protocols that look nothing like each other.

All three have been handed the same photocopied dietary handout.

This is why the program is thirteen months and not twelve weeks.

Axis-specific protocol cannot be written at intake. It can only be written after the panel. It is refined after the ninety-day repeat — because the axis responds, the picture sharpens, and the protocol adjusts to what the labs now reveal. It is adjusted again at one hundred eighty. It is stabilized across the full seasonal arc, because the HPT axis behaves differently in February than in September, and the woman who has recalibrated in summer has not yet been tested in January until she has lived through it.

What you will receive is not a diet plan. It is not an exercise prescription. It is not a protocol pulled from a binder and matched to your diagnosis.

It is a clinical interpretation of your axis — yours, specifically — translated into the dietary architecture, the training structure, the sleep and stress inputs, and the supplementation that the dysfunction in front of the clinician actually requires.

And then watched. And adjusted. For thirteen months.

That is the difference between advice and care.

"Who I work with."

She is somewhere between twenty-two and fifty-six.

If she is on the younger end of that range, she has been gaining weight since her last pregnancy, or since she went back on hormonal birth control, or since a period of acute stress that never fully resolved. Her cycle has become unreliable in a way that does not fit what her mother or her sister described. Her OB told her that her labs look fine and offered her an IUD or an SSRI. Her primary care provider told her it was stress.

If she is on the older end of that range, she is somewhere inside the perimenopausal arc — although no clinician has confirmed it, because the standard of care does not confirm perimenopause, it waits for menopause and then manages it. Her sleep fractured first. Then her temperature regulation. Then the weight around her midsection that she has never carried before. Her provider offered her a statin for her rising LDL, an SSRI for her anxiety, and a sleep aid for the three AM wakings. She left the appointment holding three prescriptions and no explanation.

She has tried things. She has tried elimination diets. She has tried a functional medicine coach on Instagram who sold her an HTMA kit. She has tried adrenal cocktails and seed cycling and cold plunges and a sixty-dollar jar of adaptogenic powder that did not change a single marker. She has tried levothyroxine. She has tried armor. She has tried a compound.

She has read. She knows what hs-CRP is. She knows the difference between Free T3 and total T3. She has asked her provider for a Reverse T3 and been told it is not clinically indicated. She knows more about her own axis than the last three clinicians who dismissed her — and she knows that knowing it has not been enough.

She is not a new patient to functional medicine. She is a patient who has been inside functional medicine and found most of it either performative, commercially extractive, or clinically thin.

What she is looking for now is not more information. It is a licensed clinician who will run the right labs, read them against the right ranges, build a protocol that matches her axis rather than a template, coordinate with her PCP rather than position herself against one, and stay in the room with her for more than eight weeks.

That is the woman I work with.

Who this program is not for.

The woman who wants a supplement protocol without a clinical relationship. The woman who wants weight loss as the primary deliverable. The woman who is not willing to coordinate care with her existing PCP. The woman who expects a cure in ninety days. The woman whose situation is straightforward hypothyroidism that responds well to appropriately dosed replacement — she does not need this program, she needs a competent endocrinologist, and I will tell her that on the discovery call.

The woman who is looking for a coach rather than a clinician. The woman who is looking for a community rather than a chart. The woman who believes the body is the enemy and the protocol is the weapon.

This is not that kind of practice.

The criterion that predicts outcome.

Across thirteen months, what separates the woman who restores function from the woman who does not is not her starting labs, her severity, her age, or her history. It is her willingness to become the expert on her own axis.

The work is clinical. The outcome is shared. The relationship is a collaboration between a licensed nurse practitioner who knows the labs and a woman who is ready to know her own.

If that is the woman reading this page, the next step is the application.

"The thirteen-month structure."

What follows is what you are actually purchasing. Not a program. A clinical relationship with a defined arc.

Intake. Week one.

A ninety-minute clinical intake conducted via telehealth. Full history — medical, reproductive, psychiatric, surgical, medication, supplement, lifestyle, occupational, and family. Review of all prior labs you can locate, including the ones your previous providers ordered and dismissed. A conversation about what has been tried, what has worked, what has not, and why you believe what you believe about your own body at this point in the arc.

At the close of intake, the baseline panel is ordered.

Baseline panel. Weeks two through four.

The panel ordered depends on the clinical picture, but at minimum it will include full thyroid (TSH, Free T3, Free T4, Reverse T3, TPO, TG), morning cortisol and DHEA-S, sex hormone panel appropriate to cycle stage (estradiol, progesterone, testosterone, SHBG), comprehensive metabolic panel, lipid panel with particle sizing, hs-CRP, fasting insulin, A1c, full iron panel with ferritin, Vitamin D, B12, folate, and homocysteine. Additional markers are added based on the intake — EBV titers for the post-viral presentation, fasting leptin for the metabolic presentation, 4-point salivary cortisol for the HPA-primary presentation, others as clinically indicated.

Labs are drawn locally through a partner lab or through your existing PCP if she is willing to coordinate.

Interpretation and protocol development. Weeks four through six.

A ninety-minute visit to walk through the full panel together. Each marker is interpreted against the functional range, against the rest of the panel, and against your symptom picture. You leave the visit understanding which axis is driving, which axes are secondary, and what the clinical trajectory looks like for your specific presentation.

The protocol is built in the week following. Diet, training, sleep, stress, nutrient repletion, and supplementation where indicated. Every element is tied to a specific marker and a specific mechanism. Nothing is generic. Nothing is included because it is trendy. You receive the written protocol with the clinical reasoning attached — so you know why each element is there and what it is intended to address.

Active implementation. Months two and three.

Biweekly visits during the first sixty days of the protocol. Thirty minutes each, telehealth. The purpose is not coaching. It is clinical monitoring — watching the body respond to the intervention, catching any adverse response early, adjusting dose and timing as needed, and answering the questions that arise as the body begins to change.

Unlimited secure messaging during this phase for clinical questions between visits. Not unlimited coaching. Clinical.

Ninety-day recalibration.

Repeat panel. Same markers as baseline, plus any that were added. A ninety-minute visit to walk through the movement. This is the visit at which the protocol is refined — because the picture has sharpened, the axis has responded, and the labs now reveal what was previously obscured.

Most patients are meaningfully different people by this visit. Morning energy is returning. Sleep is consolidating. The cycle is beginning to report accurately. The labs confirm what the patient is already feeling, and the protocol is adjusted to meet her where she is now rather than where she was at intake.

Sustained implementation. Months four through six.

Monthly visits, forty-five minutes each. The protocol is stable by this phase, but the body is not — it is still adjusting, still revealing, still integrating. The visits in this phase are where the work deepens. Where the harder patterns — the sleep architecture that needs to be rebuilt from scratch, the stress response that needs to be retrained, the eating patterns that developed during a decade of metabolic dysfunction and will not release themselves without attention — come to the surface and are addressed.

One-hundred-eighty-day recalibration.

Second repeat panel. Second ninety-minute interpretive visit. Second protocol refinement.

At this point, the picture is clear. The axis is responding. The markers are moving. The protocol is stabilizing into the form that will carry the patient through the remainder of the program and into the alumni phase.

Seasonal stabilization. Months seven through twelve.

Monthly visits, forty-five minutes. This is the phase that distinguishes a thirteen-month clinical relationship from every twelve-week program in the space. The patient has recalibrated. The question now is whether she can hold the recalibration across the full seasonal arc.

The HPT axis behaves differently in February than in September. The HPA axis is tested by the holidays, by the change in light exposure, by the transition out of summer and into the first dark quarter of the Western New York year. The patient who has stabilized in July has not yet been tested until she has lived through January. This phase is the test — and the clinician is in the room with her while she takes it.

Thirteenth-month closing panel and transition.

Final repeat panel. A ninety-minute visit to review the full thirteen-month arc — baseline to ninety to one-hundred-eighty to thirteen. The trajectory is visible in the labs. The patient has a documented clinical record of her own restoration.

The visit also covers transition. Alumni structure, maintenance protocol, the markers to watch, the seasonal patterns to anticipate, the plan for when and how to re-engage if something shifts. The program ends. The clinical relationship does not.

What is included

  • Seventeen scheduled visits across thirteen months
  • Four comprehensive lab panels (baseline, 90-day, 180-day, 13-month)
  • Custom-built protocol refined three times against serial labs
  • Unlimited secure messaging during active implementation phase
  • PCP coordination where the PCP is willing
  • Full written clinical record — intake, interpretation, protocol, adjustments, final summary — provided to the patient at close of program

What is not included

  • A supplement line to purchase
  • A proprietary protocol to follow
  • A community to belong to
  • A Facebook group
  • A weekly coaching call
  • Nutrition coaching delivered by a health coach rather than by the clinician

"The investment."

$4,997
Thirteen months. One clinical relationship.
≈ $385 / month

That is three hundred eighty-five dollars per month for a licensed clinical relationship with serial lab interpretation, custom protocol development, and seventeen scheduled visits with a board-certified nurse practitioner.

For context:

  • A single visit with an endocrinologist in Western New York runs three to five hundred dollars before insurance adjustments.
  • A functional medicine practice operating in a similar scope charges between six and twelve thousand dollars for a comparable arc — and most do not offer thirteen months.
  • A year of GLP-1 medication out of pocket is between twelve and eighteen thousand dollars and addresses a single marker.
  • The supplements you are currently purchasing through your functional medicine Instagram account likely exceed one hundred fifty dollars per month and have not changed your labs.

Three hundred eighty-five dollars per month is not the cheapest option in the space. It is the one that does the work the other options do not.

What the price does not include.

Lab costs. Panels are drawn through a partner lab or through your existing PCP. Partner lab pricing is transparent and available before you enroll — typical baseline panel runs between two hundred fifty and four hundred fifty dollars depending on which markers are clinically indicated for your presentation. If your PCP is willing to order the panel through insurance, lab cost is whatever your copay and deductible structure produces.

Supplements. Where supplementation is clinically indicated, it is recommended by marker and mechanism — not by brand affiliation. This practice does not sell supplements. You purchase what is indicated from whatever source you choose. A typical patient spends between forty and eighty dollars per month on supplementation during the active implementation phase, reducing to maintenance levels by the end of month six.

What the price does include.

Everything else. All seventeen visits. All protocol development and refinement. All between-visit clinical messaging during the active phase. The full written clinical record at the close of the program.

Health savings and flexible spending accounts.

As of the most recent New York State guidance, both the program fee and the associated lab costs are eligible expenses for payment from a Health Savings Account (HSA) or Flexible Spending Account (FSA). If you have either account through your employer, you can pay the full program fee — or the monthly installments — directly from pre-tax funds.

For most patients in the thirty-three to thirty-seven percent effective tax bracket, this reduces the effective cost of the program to approximately thirty-one hundred to thirty-three hundred dollars in after-tax terms.

You will receive an itemized superbill at the close of intake and at each subsequent visit, documenting the clinical nature of the service for HSA, FSA, and tax purposes. The superbill also allows patients with PPO insurance to submit for out-of-network reimbursement, though reimbursement is not guaranteed and varies by plan.

Lab costs drawn through the partner lab are HSA and FSA eligible as well. Labs ordered through your PCP and processed through insurance follow your existing plan structure.

"The next step."

There is no enrollment deadline. There is no waitlist of one hundred women I need you to believe in. There is no countdown timer designed to move you past a decision you have not actually made.

If the page has described you, the next step is the application.

The application is twelve questions. It takes fifteen minutes. It asks for your clinical history, your prior labs where available, the axis picture you suspect is driving, and what you have already tried. I read every application myself. I do not delegate the intake review to a virtual assistant or a scheduling service.

If the application suggests we are a clinical fit, I will offer you a discovery call. The call is thirty minutes. It is not a sales call. It is a clinical conversation in which I will ask you a short list of questions, answer whatever you bring, and tell you honestly whether this practice is the right place for the work you are describing.

If it is not, I will tell you that as well, and where I think you should go instead.

If it is, we schedule the intake and the clinical relationship begins.

One last thing.

The reader who has arrived at the bottom of this page is a woman who has been dismissed for a long time. She has read her way through most of what the internet has to say about her axis. She has paid for things that did not work. She is tired in a way that has stopped being metaphorical and started being the primary fact of her life.

If that is the woman reading now, I want to say one thing directly to you, without the page's voice in between.

You were not wrong. Your body has been reporting accurately. The labs that would have confirmed what you were feeling were not ordered, or were ordered and read against the wrong ranges, or were ordered correctly and dismissed by a clinician who did not have the time or the framework to understand what she was looking at.

None of that was your failure. It was the failure of a system doing exactly what it was designed to do, to a patient it was not designed for.

Thirteen months from now, with the right panel and the right reading and the right clinical relationship, you will be a different patient. Not a healed one — restored. To function, to signal, and to the quiet authority that comes from understanding the axis you have been living inside all along.

The application is below.

Begin the application.

Fifteen minutes. Twelve questions. I read every one.

Begin the application →

Telehealth · New York State residents · No enrollment deadline